Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,063
Closed -$8.83K 7497
2026
Q1
$8.83K Sell
13,063
-25,644
-66% -$21K ﹤0.01% 5993
2025
Q4
$35.2K Buy
38,707
+19,646
+103% +$18.8K ﹤0.01% 5653
2025
Q3
$17K Buy
19,061
+2,237
+13% +$3.25K ﹤0.01% 5834
2025
Q2
$36.3K Buy
+16,824
New +$61K ﹤0.01% 5612
2024
Q2
Sell
-212
Closed -$693 7262
2024
Q1
$693 Buy
212
+12
+6% +$44 ﹤0.01% 6228
2023
Q4
$1K Buy
200
+48
+32% +$128 ﹤0.01% 6222
2023
Q3
$169 Buy
152
+4
+3% +$3 ﹤0.01% 6627
2023
Q2
$77 Buy
148
+68
+85% +$38 ﹤0.01% 6934
2023
Q1
$60 Buy
80
+38
+90% +$22 ﹤0.01% 7062
2022
Q4
$21 Buy
42
+2
+5% +$2 ﹤0.01% 7271
2022
Q3
$0 Sell
40
-6
-13% -$11 ﹤0.01% 7116
2022
Q2
$0 Buy
46
+4
+10% +$10 ﹤0.01% 7246
2022
Q1
$0 Hold
42
﹤0.01% 7551
2021
Q4
$0 Sell
42
-1,193
-97% -$11.4K ﹤0.01% 7606
2021
Q3
$14K Sell
1,235
-3,997
-76% -$39.8K ﹤0.01% 6093
2021
Q2
$56K Buy
5,232
+4,005
+326% +$41.9K ﹤0.01% 5510
2021
Q1
$15K Buy
1,227
+1,200
+4,444% +$14.5K ﹤0.01% 6235
2020
Q4
$0 Buy
27
+7
+35% +$40 ﹤0.01% 6820
2020
Q3
$0 Buy
20
+6
+43% +$24 ﹤0.01% 6689
2020
Q2
$0 Hold
14
﹤0.01% 6631
2020
Q1
$0 Buy
+14
New +$104 ﹤0.01% 6587
2017
Q4
Sell
-33
Closed -$6K 6465
2017
Q3
$6K Sell
33
-24
-42% -$5.76K ﹤0.01% 5987
2017
Q2
$18K Buy
+57
New +$20.9K ﹤0.01% 5649

Other funds holding MYO

Wells Fargo's MYO Position: Q2 2026 in Review

Wells Fargo sold out of Myomo (MYO) in Q2 2026, closing a stake of 13,063 shares — an estimated $8.83K sold.

Wells Fargo first reported a position in MYO in Q2 2017 and held it in 23 quarters. The position peaked at $56K in Q2 2021. 80 funds tracked by Wall St. Rank hold MYO as of Q2 2026.

  • Wells Fargo reported no remaining Myomo position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 13,063 Myomo shares in Q2 2026, an estimated $8.83K.
  • Wells Fargo first reported a position in Myomo in Q2 2017 and held it in 23 quarters.
  • Wells Fargo's Myomo position peaked at $56K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.